395 related articles for article (PubMed ID: 24853951)
1. The potential role of impaired Notch signalling in atopic dermatitis.
Melnik BC
Acta Derm Venereol; 2015 Jan; 95(1):5-11. PubMed ID: 24853951
[TBL] [Abstract][Full Text] [Related]
2. Does therapeutic intervention in atopic dermatitis normalize epidermal Notch deficiency?
Melnik BC
Exp Dermatol; 2014 Oct; 23(10):696-700. PubMed ID: 24889007
[TBL] [Abstract][Full Text] [Related]
3. Cellular and molecular mechanisms in atopic dermatitis.
Oyoshi MK; He R; Kumar L; Yoon J; Geha RS
Adv Immunol; 2009; 102():135-226. PubMed ID: 19477321
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor 2 ligands promote chronic atopic dermatitis through IL-4-mediated suppression of IL-10.
Kaesler S; Volz T; Skabytska Y; Köberle M; Hein U; Chen KM; Guenova E; Wölbing F; Röcken M; Biedermann T
J Allergy Clin Immunol; 2014 Jul; 134(1):92-9. PubMed ID: 24698321
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E
Sawada Y; Honda T; Nakamizo S; Nakajima S; Nonomura Y; Otsuka A; Egawa G; Yoshimoto T; Nakamura M; Narumiya S; Kabashima K
J Allergy Clin Immunol; 2019 Nov; 144(5):1265-1273.e9. PubMed ID: 31301371
[TBL] [Abstract][Full Text] [Related]
6. Current Understanding of Pathophysiological Mechanisms of Atopic Dermatitis: Interactions among Skin Barrier Dysfunction, Immune Abnormalities and Pruritus.
Fujii M
Biol Pharm Bull; 2020; 43(1):12-19. PubMed ID: 31902917
[TBL] [Abstract][Full Text] [Related]
7. Atopic dermatitis-like disease and associated lethal myeloproliferative disorder arise from loss of Notch signaling in the murine skin.
Dumortier A; Durham AD; Di Piazza M; Vauclair S; Koch U; Ferrand G; Ferrero I; Demehri S; Song LL; Farr AG; Leonard WJ; Kopan R; Miele L; Hohl D; Finke D; Radtke F
PLoS One; 2010 Feb; 5(2):e9258. PubMed ID: 20174635
[TBL] [Abstract][Full Text] [Related]
8. Th2 Modulation of Transient Receptor Potential Channels: An Unmet Therapeutic Intervention for Atopic Dermatitis.
Meng J; Li Y; Fischer MJM; Steinhoff M; Chen W; Wang J
Front Immunol; 2021; 12():696784. PubMed ID: 34276687
[TBL] [Abstract][Full Text] [Related]
9. Selective ablation of Ctip2/Bcl11b in epidermal keratinocytes triggers atopic dermatitis-like skin inflammatory responses in adult mice.
Wang Z; Zhang LJ; Guha G; Li S; Kyrylkova K; Kioussi C; Leid M; Ganguli-Indra G; Indra AK
PLoS One; 2012; 7(12):e51262. PubMed ID: 23284675
[TBL] [Abstract][Full Text] [Related]
10. Epidermal tight junction barrier function is altered by skin inflammation, but not by filaggrin-deficient stratum corneum.
Yokouchi M; Kubo A; Kawasaki H; Yoshida K; Ishii K; Furuse M; Amagai M
J Dermatol Sci; 2015 Jan; 77(1):28-36. PubMed ID: 25511077
[TBL] [Abstract][Full Text] [Related]
11. Atopic dermatitis induces the expansion of thymus-derived regulatory T cells exhibiting a Th2-like phenotype in mice.
Moosbrugger-Martinz V; Tripp CH; Clausen BE; Schmuth M; Dubrac S
J Cell Mol Med; 2016 May; 20(5):930-8. PubMed ID: 26931745
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous atopic dermatitis-like symptoms in a/a ma ft/ma ft/J flaky tail mice appear early after birth.
Kypriotou M; Boéchat C; Huber M; Hohl D
PLoS One; 2013; 8(7):e67869. PubMed ID: 23844115
[TBL] [Abstract][Full Text] [Related]
13. IL-1β induces thymic stromal lymphopoietin and an atopic dermatitis-like phenotype in reconstructed healthy human epidermis.
Bernard M; Carrasco C; Laoubi L; Guiraud B; Rozières A; Goujon C; Duplan H; Bessou-Touya S; Nicolas JF; Vocanson M; Galliano MF
J Pathol; 2017 Jun; 242(2):234-245. PubMed ID: 28191908
[TBL] [Abstract][Full Text] [Related]
14. Impaired Notch-MKP-1 signalling in hidradenitis suppurativa: an approach to pathogenesis by evidence from translational biology.
Melnik BC; Plewig G
Exp Dermatol; 2013 Mar; 22(3):172-7. PubMed ID: 23489419
[TBL] [Abstract][Full Text] [Related]
15. The Janus kinase inhibitor JTE-052 improves skin barrier function through suppressing signal transducer and activator of transcription 3 signaling.
Amano W; Nakajima S; Kunugi H; Numata Y; Kitoh A; Egawa G; Dainichi T; Honda T; Otsuka A; Kimoto Y; Yamamoto Y; Tanimoto A; Matsushita M; Miyachi Y; Kabashima K
J Allergy Clin Immunol; 2015 Sep; 136(3):667-677.e7. PubMed ID: 26115905
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-33 in atopic dermatitis.
Imai Y
J Dermatol Sci; 2019 Oct; 96(1):2-7. PubMed ID: 31455506
[TBL] [Abstract][Full Text] [Related]
17. Atopic dermatitis: immune deviation, barrier dysfunction, IgE autoreactivity and new therapies.
Furue M; Chiba T; Tsuji G; Ulzii D; Kido-Nakahara M; Nakahara T; Kadono T
Allergol Int; 2017 Jul; 66(3):398-403. PubMed ID: 28057434
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-146a alleviates chronic skin inflammation in atopic dermatitis through suppression of innate immune responses in keratinocytes.
Rebane A; Runnel T; Aab A; Maslovskaja J; Rückert B; Zimmermann M; Plaas M; Kärner J; Treis A; Pihlap M; Haljasorg U; Hermann H; Nagy N; Kemeny L; Erm T; Kingo K; Li M; Boldin MP; Akdis CA
J Allergy Clin Immunol; 2014 Oct; 134(4):836-847.e11. PubMed ID: 24996260
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid 1 receptors in keratinocytes attenuate fluorescein isothiocyanate-induced mouse atopic-like dermatitis.
Gaffal E; Glodde N; Jakobs M; Bald T; Tüting T
Exp Dermatol; 2014 Jun; 23(6):401-6. PubMed ID: 24750433
[TBL] [Abstract][Full Text] [Related]
20. Counterregulation between thymic stromal lymphopoietin- and IL-23-driven immune axes shapes skin inflammation in mice with epidermal barrier defects.
Li J; Leyva-Castillo JM; Hener P; Eisenmann A; Zaafouri S; Jonca N; Serre G; Birling MC; Li M
J Allergy Clin Immunol; 2016 Jul; 138(1):150-161.e13. PubMed ID: 26993035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
